Home Newsfeeds Value Line Q1 EPS $0.47 Down From $0.62 YoY

Value Line Q1 EPS $0.47 Down From $0.62 YoY

Value Line (NASDAQ:VALU) reported quarterly earnings of $0.47 per share. This is a 24.19 percent decrease over earnings of $0.62 per share from the same period last year.

byBenzinga Newsdesk

September 14, 2022

1 minute read

Value Line (NASDAQ:VALU) reported quarterly earnings of $0.47 per share. This is a 24.19 percent decrease over earnings of $0.62 per share from the same period last year.

What Is Precision BioSciences CAR T Pipeline Value? Analyst Lowers Price Target To Justify Valuation

By Vandana Singh

August 17, 2:18 PM

Wednesday, Precision BioSciences Inc (NASDAQ: DTIL) announced the completion of a strategic transaction with Imugene Limited for global rights to Azercabtagene Zapreleucel (azer-cel), Precision's lead allogeneic CAR T candidate for cancer.